SCHEMBL22751116

SCHEMBL22751116

CC(CCC(C)(C)N1CCN(C(C)(C)C)C1=S)N1CCN(C(C)(C)C)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21533953 0.79 — —
SCHEMBL21690604 0.77 — —
SCHEMBL24335867 0.74 PKM (0.30) —
SCHEMBL12528611 0.69 PIK3CD (0.33) —
SCHEMBL21324893 0.67 — —
SCHEMBL21325293 0.66 — —
SCHEMBL18643112 0.64 PIK3CD (0.30) —
SCHEMBL611663 0.62 POLB (0.35) —
SCHEMBL19443027 0.60 PER2 (0.36) —
SCHEMBL25666129 0.59 HRH3 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10858344-B2 Hydantoin containing deoxyuridine triphosphatase inhibitors CV6 THERAPEUTICS (NI) LIMITED (GB) 2020-12-08 — — US disclosed
Send feedback